Integrative Cancer Therapies journal accepted into prestigious ISI index
Integrative Cancer Therapies (ICT) published by SAGE Publications, has been accepted by Thomson Scientific (formerly ISI), for inclusion in the Science Citation Index ExpandedTM (see http://scientific.thomson.com/products/scie). ICT features articles and studies focusing on evidence - and science-based understanding of the mechanisms of integrative cancer treatments, which combines the best conventional cancer therapies with complementary and alternative medicine (CAM).
"Inclusion in ISI is a powerful sign that ICT is becoming an important player in the world of scientific information resources," said Editor-in-Chief Keith I. Block, MD. Dr. Block is also Medical and Scientific Director of the Block Center for Integrative Cancer Treatment in Evanston, IL.
ICT will receive its first official Impact Factor in the 2008 Journal Citation Reports®, which comes out in summer 2009.
The Impact Factor is a measurement of a journal's influence in the scientific publishing community based on the number of times a journal's articles are cited.
"Our authors made this possible and we anticipate many more influential articles and insights in the area of evidenced-based scientific inquiry of integrative cancer therapies," Dr. Block said.
In fact, the journal has generated a significant amount of media attention. Findings reported in the article "Diagnostic Accuracy of Canine Scent Detection in Early and Late Stage Lung and Breast Cancers" published in the March 2006 issue were featured on NBC's Today Show, CNN's Paula Zahn Now, The New York Times, National Geographic, CBS News Online, New Scientist, and the Toronto Star.
The September issue features many interesting and innovative articles including:
"Potential Attenuation of Disease Progression in Recurrent Prostate Cancer With Plant-Based Diet"
"Tai Chi Chuan: Mind-Body Practice or Exercise Intervention? Studying the Benefit for Cancer Survivors"
"Extraction-Dependent Effects of American Ginseng (Panax quinquifolium) on Human Breast Cancer Cell Proliferation and Estrogen Receptor Activation"
Preadministration of High-Dose Salicylates, Suppressors of NF-kB Activation, May Increase the Chemosensitivity of Many Cancers
"Integrative cancer treatment incorporates the best of conventional interventions with meaningful, complementary therapies, and individualizes each patient's care regimen. Treatment plans may include chemotherapy, chronomodulated chemotherapy (circadian-timed chemotherapy), prescriptive exercise, nutritional pharmacology, scientifically tailored supplements, mind/body work and physical therapy," Dr. Block explains. "This acknowledgment by ISI will help professionals and patients alike understand ICT is a forum for disseminating information about groundbreaking and forward-looking work and I congratulate our editorial staff, editorial and advisory boards, and contributors to ICT for this important recognition."
To sign up for ICT Email alerts register at http://ict.sagepub.com and click "Email alerts."
About Integrative Cancer Therapies: Written for everyone involved in comprehensive cancer treatment and care--from physicians and other health care professionals to complementary and alternative practitioners to informed patients-- Integrative Cancer Therapies focuses on evidence based and scientifically sound understanding of the mechanisms of cancer therapies and the physiology of disease conditions, as well as the psychosocial and spiritual needs of the patient. The journal is edited by Dr. Keith Block, Medical and Scientific Director of the Institute for Integrative Cancer Treatment. http://ict.sagepub.com
SAGE Publications is a leading international publisher of journals, books, and electronic media for academic, educational, and professional markets. Since 1965, SAGE has helped inform and educate a global community of scholars, practitioners, researchers, and students spanning a wide range of subject areas including business, humanities, social sciences, and science, technology and medicine. SAGE Publications, a privately owned corporation, has principal offices in Thousand Oaks, California, London, United Kingdom, and New Delhi, India. www.sagepublications.com
The Block Center for Integrative Cancer Treatment, located in Evanston, Illinois, was founded in 1980 by Penny and Keith Block, MD, with a focus on treating the patient as a whole person, not simply treating the diagnosis. The Center's research-based treatment integrates an innovative approach to the best of conventional medicine with scientifically sound complementary therapies -- therapeutic nutrition, botanical and phytonutrient supplementation, prescriptive exercise, and systematic mind-body strategies, to enhance the recovery process. Block has pioneered this "middle ground" approach to cancer care and optimal health – designing a total treatment plan that is tailored to the precise needs of each patient, using a unique set of clinical and laboratory assessments. The Block Center is breaking new ground with the creation and development of Cancer Rehab as an innovative treatment modality, and is currently the only private North American medical center using chronomodulated chemotherapy. Dr. Block is a member of the National Cancer Institute's PDQ Cancer Complementary and Alternative Medicine (CAM) Editorial Board in Washington, D.C., and Director of Integrative Medical Education at the College of Medicine at the University of Illinois, Chicago. The Block Center is a full treatment clinic, has served as a CCOP site through the National Cancer Institute, and is currently engaged in clinical cancer research with the University of Illinois and other university facilities in the United States and Israel (www.blockmd.com).
Published on PsychCentral.com. All rights reserved.